Allosteric modulation of G protein-coupled receptors.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Annual Review of Pharmacology and Toxicology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1146/annurev.pharmtox.47.120505.105159PMID 17009927
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of key amino acids implicated in the actions of allosteric modulation by 3,3'-difluorobenzaldazine on rat mGlu5 receptors.

  2006cited by this paper
• Identification of a Zn2+-binding site on the dopamine D2 receptor.

  2006cited by this paper
• GPCR modulation by RAMPs.

  2006cited by this paper
• Structural and Molecular Interactions of CCR5 Inhibitors with CCR5*

  2006cited by this paper
• Allosteric Modulation of Binding Properties between Units of Chemokine Receptor Homo- and Hetero-Oligomers

  2006cited by this paper
• A Novel Class of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 1 Interact with a Site Distinct from That of Negative Allosteric Modulators

  2006cited by this paper
• Interaction of small molecule inhibitors of HIV-1 entry with CCR5.

  2006cited by this paper
• Probing the Molecular Mechanism of Interaction between 4-n-Butyl-1-[4-(2-methylphenyl)-4-oxo-1-butyl]-piperidine (AC-42) and the Muscarinic M1 Receptor: Direct Pharmacological Evidence That AC-42 Is an Allosteric Agonist

  2006cited by this paper
• Ago-Allosteric Modulation and Other Types of Allostery in Dimeric 7TM Receptors

  2006cited by this paper
• Regulation of m1 muscarinic receptors and nNOS mRNA levels by autoantibodies from schizophrenic patients.

  2006cited by this paper
• Design, synthesis, and action of oxotremorine-related hybrid-type allosteric modulators of muscarinic acetylcholine receptors.

  2006cited by this paper
• Allosteric Interactions with Muscarinic Acetylcholine Receptors: Complex Role of the Conserved Tryptophan M2422Trp in a Critical Cluster of Amino Acids for Baseline Affinity, Subtype Selectivity, and Cooperativity

  2006cited by this paper
• The changing landscape of protein allostery.

  2006cited by this paper
• Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes*

  2005cited by this paper
• Allosteric Modulation of the Cannabinoid CB1 Receptor

  2005cited by this paper
• Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors.

  2005cited by this paper
• Modulation of Agonist Binding to Human Dopamine Receptor Subtypes by l-Prolyl-l-leucyl-glycinamide and a Peptidomimetic Analog

  2005cited by this paper
• Analysis of Allosterism in Functional Assays

  2005cited by this paper
• Atypical Muscarinic Allosteric Modulation: Cooperativity between Modulators and Their Atypical Binding Topology in Muscarinic M2 and M2/M5 Chimeric Receptors

  2005cited by this paper
• Allosteric functioning of dimeric class C G‐protein‐coupled receptors

  2005cited by this paper
• The CCR5 Receptor-Based Mechanism of Action of 873140, a Potent Allosteric Noncompetitive HIV Entry Inhibitor

  2005cited by this paper
• Regulation of M2 Muscarinic Acetylcholine Receptor Expression and Signaling by Prolonged Exposure to Allosteric Modulators

  2005cited by this paper
• Principles: a model for the allosteric interactions between ligand binding sites within a dimeric GPCR.

  2005cited by this paper
• Allosteric modulators affect the internalization of human adenosine A1 receptors.

  2005cited by this paper
• Glycoprotein hormone receptors: link between receptor homodimerization and negative cooperativity

  2005cited by this paper
• A selective metabotropic glutamate receptor 7 agonist: activation of receptor signaling via an allosteric site modulates stress parameters in vivo.

  2005cited by this paper
• Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling.

  2005cited by this paper
• New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism

  2005cited by this paper
• A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models

  2005cited by this paper
• Critical Amino Acid Residues of the Common Allosteric Site on the M2 Muscarinic Acetylcholine Receptor: More Similarities than Differences between the Structurally Divergent Agents Gallamine and Bis(ammonio)alkane-Type Hexamethylene-bis-[dimethyl-(3-phthalimidopropyl)ammonium]dibromide

  2005cited by this paper
• Molecular Mechanism of AMD3100 Antagonism in the CXCR4 Receptor

  2004cited by this paper
• Allosteric modulation of G protein-coupled receptors.

  2004cited by this paper
• Investigation of the Interaction of a Putative Allosteric Modulator, N-(2,3-Diphenyl-1,2,4-thiadiazole-5-(2H)-ylidene) Methanamine Hydrobromide (SCH-202676), with M1 Muscarinic Acetylcholine Receptors

  2004cited by this paper
• Effects of anandamide on the binding and signaling properties of M1 muscarinic acetylcholine receptors.

  2004cited by this paper
• Cooperative Conformational Changes in a G-protein-coupled Receptor Dimer, the Leukotriene B4 Receptor BLT1*

  2004cited by this paper
• Allosteric modulators: the new generation of receptor antagonist.

  2004cited by this paper
• Application of a Kinetic Model to the Apparently Complex Behavior of Negative and Positive Allosteric Modulators of Muscarinic Acetylcholine Receptors

  2004cited by this paper
• Selected amino acids, dipeptides and arylalkylamine derivatives do not act as allosteric modulators at GABAB receptors.

  2004cited by this paper
• Homology Modeling of the Transmembrane Domain of the Human Calcium Sensing Receptor and Localization of an Allosteric Binding Site*

  2004cited by this paper
• Designing human m1 muscarinic receptor-targeted hydrophobic eigenmode matched peptides as functional modulators.

  2004cited by this paper
• Searching for new allosteric sites in enzymes.

  2004cited by this paper
• Modulation of the M2 Muscarinic Acetylcholine Receptor Activity with Monoclonal Anti-M2 Receptor Antibody Fragments*

  2004cited by this paper
• Thiochrome enhances acetylcholine affinity at muscarinic M4 receptors: receptor subtype selectivity via cooperativity rather than affinity.

  2004cited by this paper
• Spirodiketopiperazine-Based CCR5 Inhibitor Which Preserves CC-Chemokine/CCR5 Interactions and Exerts Potent Activity against R5 Human Immunodeficiency Virus Type 1 In Vitro

  2004cited by this paper
• Quantitative analysis of allosteric drug-protein binding by biointeraction chromatography

  2004cited by this paper
• The Heptahelical Domain of GABAB2 Is Activated Directly by CGP7930, a Positive Allosteric Modulator of the GABAB Receptor*

  2004cited by this paper
• A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.

  2004cited by this paper
• Refinement of a homology model of the mu-opioid receptor using distance constraints from intrinsic and engineered zinc-binding sites.

  2004cited by this paper
• Mutational Analysis and Molecular Modeling of the Allosteric Binding Site of a Novel, Selective, Noncompetitive Antagonist of the Metabotropic Glutamate 1 Receptor*

  2003cited by this paper
• Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors

  2003cited by this paper
• Identification of an allosteric binding site for Zn2+ on the beta2 adrenergic receptor.

  2003cited by this paper
• Pharmacological characterization and identification of amino acids involved in the positive modulation of metabotropic glutamate receptor subtype 2.

  2003cited by this paper
• Identification of Allosteric Peptide Agonists of CXCR4*

  2003cited by this paper
• The bicyclam AMD3100 story

  2003cited by this paper
• scFv Single Chain Antibody Variable Fragment as Inverse Agonist of the β2-Adrenergic Receptor*

  2003cited by this paper
• Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists.

  2003cited by this paper
• N,N′-Dicyclopentyl-2-methylsulfanyl-5-nitro-pyrimidine-4,6-diamine (GS39783) and Structurally Related Compounds: Novel Allosteric Enhancers of γ-Aminobutyric AcidB Receptor Function

  2003cited by this paper
• Identification of an Allosteric Binding Site for Zn2+on the β2 Adrenergic Receptor*

  2003cited by this paper
• Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.

  2003cited by this paper
• Analysis of the Mechanism by Which the Small-Molecule CCR5 Antagonists SCH-351125 and SCH-350581 Inhibit Human Immunodeficiency Virus Type 1 Entry

  2003cited by this paper
• Modeling and Mutagenesis of the Binding Site of Calhex 231, a Novel Negative Allosteric Modulator of the Extracellular Ca2+-sensing Receptor*

  2003cited by this paper
• International Union of Pharmacology Committee on Receptor Nomenclature and Drug Classification. XXXVIII. Update on Terms and Symbols in Quantitative Pharmacology

  2003cited by this paper
• [3H]R214127: a novel high-affinity radioligand for the mGlu1 receptor reveals a common binding site shared by multiple allosteric antagonists.

  2003cited by this paper
• Identification of essential residues involved in the allosteric modulation of the human A(3) adenosine receptor.

  2003cited by this paper
• Cellular and Behavioral Effects of D2 Dopamine Receptor Hydrophobic Eigenmode-Targeted Peptide Ligands

  2003cited by this paper
• The bicyclam AMD3100 story

  2003cited by this paper
• Structure‐based identification of binding sites, native ligands and potential inhibitors for G‐protein coupled receptors

  2003cited by this paper
• Allosteric enhancers of A1 adenosine receptors increase receptor-G protein coupling and counteract Guanine nucleotide effects on agonist binding.

  2003cited by this paper
• Receptor Activity-modifying Protein 1 Determines the Species Selectivity of Non-peptide CGRP Receptor Antagonists* 210

  2002cited by this paper
• Analogs of WIN 62,577 define a second allosteric site on muscarinic receptors.

  2002cited by this paper
• G Protein-Coupled Receptor Allosterism and Complexing

  2002cited by this paper
• G protein-coupled receptor interacting proteins: emerging roles in localization and signal transduction.

  2002cited by this paper
• Allosteric modulation of muscarinic receptor signaling: alcuronium-induced conversion of pilocarpine from an agonist into an antagonist.

  2002cited by this paper
• Discovery of an ectopic activation site on the M(1) muscarinic receptor.

  2002cited by this paper
• Allosteric binding sites on cell-surface receptors: novel targets for drug discovery

  2002cited by this paper
• Identification of Acidic Residues in the Extracellular Loops of the Seven-transmembrane Domain of the Human Ca2+ Receptor Critical for Response to Ca2+ and a Positive Allosteric Modulator*

  2002cited by this paper
• Crystal Structure of Rhodopsin: A G‐Protein‐Coupled Receptor

  2002cited by this paper
• Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands.

  2002cited by this paper
• Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site

  2002cited by this paper
• Metal Ion-mediated Agonism and Agonist Enhancement in Melanocortin MC1 and MC4 Receptors*

  2002cited by this paper
• GPCR drug discovery through the exploitation of allosteric drug binding sites.

  2002cited by this paper
• Receptor classification: post genome.

  2002cited by this paper
• Agonist-like activity of antibodies directed against the second extracellular loop of the human cardiac serotonin 5-HT4(e) receptor in transfected COS-7 cells.

  2002cited by this paper
• ATP-dependent Activation of the Intermediate Conductance, Ca2+-activated K+ Channel, hIK1, Is Conferred by a C-terminal Domain*

  2001cited by this paper
• Changes of cooperativity between N-methylscopolamine and allosteric modulators alcuronium and gallamine induced by mutations of external loops of muscarinic M(3) receptors.

  2001cited by this paper
• ATP-dependent activation of the intermediate conductance, Ca2+-activated K+ channel, hIK1, is conferred by a C-terminal domain.

  2001cited by this paper
• Calcilytic compounds: potent and selective Ca2+ receptor antagonists that stimulate secretion of parathyroid hormone.

  2001cited by this paper
• Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site

  2001cited by this paper
• Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor.

  2001cited by this paper
• Molecular modelling study of the role of cholesterol in the stimulation of the oxytocin receptor.

  2001cited by this paper
• Molecular Interactions of Cyclam and Bicyclam Non-peptide Antagonists with the CXCR4 Chemokine Receptor*

  2001cited by this paper
• Mutation of Asp(171) and Asp(262) of the chemokine receptor CXCR4 impairs its coreceptor function for human immunodeficiency virus-1 entry and abrogates the antagonistic activity of AMD3100.

  2001cited by this paper
• Oligomerization of G-protein-coupled transmitter receptors

  2001cited by this paper
• Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501.

  2001cited by this paper
• Allosteric modulation of A(3) adenosine receptors by a series of 3-(2-pyridinyl)isoquinoline derivatives.

  2001cited by this paper
• The binding-site crevice of the D4 dopamine receptor is coupled to three distinct sites of allosteric modulation.

  2001cited by this paper
• The Non-competitive Antagonists 2-Methyl-6-(phenylethynyl)pyridine and 7-Hydroxyiminocyclopropan[b]chromen-1a-carboxylic Acid Ethyl Ester Interact with Overlapping Binding Pockets in the Transmembrane Region of Group I Metabotropic Glutamate Receptors*

  2000cited by this paper
• Ca(2+) requirement for high-affinity gamma-aminobutyric acid (GABA) binding at GABA(B) receptors: involvement of serine 269 of the GABA(B)R1 subunit.

  2000cited by this paper
• Crystal structure of rhodopsin: A G protein-coupled receptor.

  2000cited by this paper
• Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site.

  2000cited by this paper

• The pathway-independent positive allosteric modulator C1 allows for the identification of active Y4 receptor relevant positions

  2026cites this paper
• Drug-target residence time: Analyzing cooperativity effects in G protein-coupled receptors by mathematical modeling and molecular dynamics simulations.

  2026cites this paper
• Biased signaling in drug discovery and precision medicine.

  2025cites this paper
• Targeting mGluR7 in Parkinson’s disease: a novel approach to neuroprotection and synaptic therapies

  2025cites this paper
• The Prosperity and Adversity of M4 Muscarinic Acetylcholine Receptor Activators in the Treatment of Neuropsychiatric Disorders.

  2025cites this paper
• Advances in cannabinoid receptors pharmacology: from receptor structural insights to ligand discovery

  2025cites this paper
• The Highly Selective Discovery of Allosteric Ligands from Herbal Extracts through Their Direct Interactions with the Immobilized Headless CaSR Truncation

  2025cites this paper
• Structure-based discovery of positive allosteric modulators of the A1 adenosine receptor

  2025cites this paper
• Novel Orthosteric/Allosteric Ligands of Cannabinoid Receptors: An Unexpected Pharmacological Profile.

  2025cites this paper
• Structural insights into lipid chain-length selectivity and allosteric regulation of FFA2

  2025cites this paper
• Profiling Allosteric Modulators of CB1R with an Allosteric Fluoroprobe.

  2025cites this paper
• Attributes novel drug candidate: Constitutive GPCR signal bias mediated by purinergic receptors.

  2025cites this paper
• The Role and Mechanisms of G protein-coupled receptors in Parkinson's disease

  2025cites this paper
• Twisted Host–Guest Systems Exhibit Superamplification of Asymmetry via Coupled Strong Association and Helicity-Driven Cooperativity

  2025cites this paper
• Intracellular GPCR modulators enable precision pharmacology

  2025cites this paper
• Dynamic energy conversion in protein catalysis: From brownian motion to enzymatic function

  2025cites this paper
• A mathematical formalism to quantify drug-target residence time.

  2025cites this paper
• Integrated structural analysis of sex hormone binding globulin reveals allosteric modulation by distant mutations.

  2025cites this paper
• A golden age of muscarinic acetylcholine receptor modulation in neurological diseases

  2024cites this paper
• Gut microbe-generated phenylacetylglutamine is an endogenous allosteric modulator of β2-adrenergic receptors

  2024cites this paper
• Charge Movements and Conformational Changes: Biophysical Properties and Physiology of Voltage-Dependent GPCRs

  2024cites this paper
• Voltage dependence of M2 muscarinic receptor antagonists and allosteric modulators.

  2024cites this paper
• Dissecting Allosteric Mutations for Antibiotic Resistance by Time-Dependent Linear Response Theory.

  2024cites this paper
• Structural basis of positive allosteric modulation of metabotropic glutamate receptor activation and internalization

  2024cites this paper
• Bitopic Ligands Support the Presence of a Metastable Binding Site at the β2 Adrenergic Receptor.

  2024cites this paper
• Review on allosteric modulators of dopamine receptors so far

  2024cites this paper
• Mpemba-Like Sensory Withdrawal Effect

  2024cites this paper
• The path to the G protein‐coupled receptor structural landscape: Major milestones and future directions

  2024cites this paper
• The lactate receptor HCAR1: A key modulator of epileptic seizure activity

  2024cites this paper
• AI approaches for the discovery and validation of drug targets

  2024cites this paper
• Pharmacological characterization of allosteric modulators: A case for chemokine receptors

  2024cites this paper
• The novel orthosteric agonist M1 muscarinic acetylcholine receptor reveals anti-Alzheimer’s disease activity

  2024cites this paper
• Illuminating the neuropeptide Y4 receptor and its ligand pancreatic polypeptide from a structural, functional, and therapeutic perspective.

  2024cites this paper
• Positive allosteric modulation of a GPCR ternary complex

  2024cites this paper
• Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors

  2023cites this paper
• Brain Structure and Function: Insights from Chemical Neuroanatomy

  2023cites this paper
• Monitoring GPCR conformation with GFP-inspired dyes

  2023cites this paper
• An Update of G-Protein-Coupled Receptor Signaling and Its Deregulation in Gastric Carcinogenesis

  2023cites this paper
• The impact of cryo-EM on determining allosteric modulator-bound structures of G protein-coupled receptors.

  2023cites this paper
• Problems and prospects for finding new pharmacological agents among adenosine receptor agonists, antagonists, or their allosteric modulators for the treatment of cardiovascular diseases.

  2023cites this paper
• Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors

  2023cites this paper
• Advances in the allostery of angiotensin II type 1 receptor

  2023cites this paper
• Nanobody-Mediated Dualsteric Engagement of the Angiotensin Receptor Broadens Biased Ligand Pharmacology

  2023cites this paper
• Emergence of Single- versus Multi-State Allostery

  2023cites this paper
• Bridging the Binding Sites 2.0: Photoswitchable Dualsteric Ligands for the Cannabinoid 2 Receptor.

  2023cites this paper
• Dynamic allosteric networks drive adenosine A1 receptor activation and G-protein coupling

  2023cites this paper
• Xanomeline displays concomitant orthosteric and allosteric binding modes at the M4 mAChR

  2023cites this paper
• Location bias: A “Hidden Variable” in GPCR pharmacology

  2023cites this paper
• Allosteric modulation of G protein-coupled receptors as a novel therapeutic strategy in neuropathic pain

  2023cites this paper
• Small molecule allosteric modulation of the adenosine A1 receptor

  2023cites this paper
• Structure-Activity Relationship Study of the High-Affinity Neuropeptide Y4 Receptor Positive Allosteric Modulator VU0506013.

  2023cites this paper
• Structural basis of α1A-adrenergic receptor activation and recognition by an extracellular nanobody

  2023cites this paper
• Structural basis of allosteric modulation of metabotropic glutamate receptor activation and desensitization

  2023cites this paper
• Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors

  2023cites this paper
• Therapeutic potential of allosteric modulators for the treatment of gastrointestinal motility disorders

  2022cites this paper
• Mutual Cooperativity of Three Allosteric Sites on the Dopamine D1 Receptor

  2022cites this paper
• [Biased Signaling through G Protein-coupled Receptors].

  2022cites this paper
• Conservation of Allosteric Ligand Binding Sites in G-Protein Coupled Receptors

  2022cites this paper
• Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery

  2022cites this paper
• Natriuretic peptide pathways in heart failure: further therapeutic possibilities

  2022cites this paper
• Impact of lactisole on the time-intensity profile of selected sweeteners in dependence of the binding site

  2022cites this paper
• Ensemble Docking Approach to Mitigate Pregnane X Receptor-Mediated CYP3A4 Induction Risk

  2022cites this paper
• Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.

  2022cites this paper
• Machine Learning for Discovery of New ADORA Modulators

  2022cites this paper
• Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic Ligands

  2022cites this paper
• Pharmacology of Antagonism of GPCR.

  2022cites this paper
• Adenosine receptor signalling in Alzheimer’s disease

  2022cites this paper
• Unmasking allosteric-binding sites: novel targets for GPCR drug discovery

  2022cites this paper
• Allosteric modulation of dopamine D2L receptor in complex with Gi1 and Gi2 proteins: the effect of subtle structural and stereochemical ligand modifications

  2022cites this paper
• The activity of the serotonergic 5-HT1A receptor is modulated by voltage and sodium levels

  2022cites this paper
• A Concise and Useful Guide to Understand How Alpha1 Adrenoceptor Antagonists Work.

  2022cites this paper
• Allosteric ligands to study medium and long chain free fatty acid GPCRs

  2022cites this paper
• Affinity Assays for Cannabinoids Detection: Are They Amenable to On-Site Screening?

  2022cites this paper
• The Nonpeptide Agonist MK-5046 Functions As an Allosteric Agonist for the Bombesin Receptor Subtype-3

  2022cites this paper
• Kinetic model of GPCR-G protein interactions reveals allokairic modulation of signaling

  2022cites this paper
• New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type‐1 cannabinoid receptor (CB1R) activity and function

  2021cites this paper
• Positive allosteric mechanisms of adenosine A1 receptor-mediated analgesia

  2021cites this paper
• L-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter.

  2021cites this paper
• Protein Function | Allostery in Proteins: Canonical Models and New Insights

  2021cites this paper
• A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of β-caryophyllene, a dietary cannabinoid.

  2021cites this paper
• Imaging Cannabinoid Receptors: A Brief Collection of Covalent and Fluorescent Probes for CB1 and CB2 Receptors

  2021cites this paper
• Heteromerization between α2A adrenoceptors and different polymorphic variants of the dopamine D4 receptor determines pharmacological and functional differences. Implications for impulsive-control disorders.

  2021cites this paper
• Advancements in folate receptor targeting for anti-cancer therapy: A small molecule-drug conjugate approach.

  2021cites this paper
• Coordination chemogenetics for activation of GPCR-type glutamate receptors in brain tissue

  2021cites this paper
• Discovery of small molecule positive allosteric modulators of the secretin receptor.

  2021cites this paper
• Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias

  2021cites this paper
• Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A1 Receptor in Living Cells.

  2021cites this paper
• Structural Characterization of Receptor–Receptor Interactions in the Allosteric Modulation of G Protein-Coupled Receptor (GPCR) Dimers

  2021cites this paper
• Positive allosteric modulation of endogenous delta opioid receptor signaling in the enteric nervous system is a potential treatment for gut motility disorders.

  2021cites this paper
• Targeting GPCRs Via Multi-Platforms Arrays and AI

  2021cites this paper
• Characterisation of bis(4-aminoquinoline)s as α1A adrenoceptor allosteric modulators.

  2021cites this paper
• Novel positive allosteric modulator of protease‐activated receptor 1 promotes skin wound healing in hairless mice

  2021cites this paper
• Variously substituted 2-oxopyridine derivatives: Extending the structure-activity relationships for allosteric modulation of the cannabinoid CB2 receptor.

  2020cites this paper
• Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia.

  2020cites this paper
• Drug Development in Channelopathies: Allosteric Modulation of Ligand-Gated and Voltage-Gated Ion Channels.

  2020cites this paper
• Cannabidiol Acts at 5-HT1A Receptors in the Human Brain: Relevance for Treating Temporal Lobe Epilepsy

  2020cites this paper
• Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids.

  2020cites this paper
• CB1 allosteric modulators and their therapeutic potential in CNS disorders.

  2020cites this paper
• "Adenosine an old player with new possibilities in kidney diseases": Preclinical evidences and clinical perspectives.

  2020cites this paper
• Development of Novel 4-Arylpyridin-2-one and 6-Arylpyrimidin-4-one Positive Allosteric Modulators of the M1 Muscarinic Acetylcholine Receptor

  2020cites this paper